Blog
RSS FeedPosted by Michael Wonder on 03 Apr 2019
Gottlieb signs off with flair – and pledge of further drug price commentary
3 April 2019 - Highlights issues of insulin prices and competition. ...
Posted by Michael Wonder on 02 Apr 2019
Statement from FDA Commissioner on the agency’s continued efforts to bring competition to the insulin market to lower prices and expand access
2 April 2019 - Access to affordable insulin can be a matter of life and death for Americans with diabetes. ...
Posted by Michael Wonder on 28 Mar 2019
Why J&J raced to put drug prices in some TV ads
28 March 2019 - One notion proposed by the Trump administration to blunt the rising cost of medicines is to ...
Posted by Michael Wonder on 27 Mar 2019
Novartis makes new MS drug cheaper than its older option
27 March 2019 - Swiss drug maker’s Mayzent will cost less than older Gilenya. ...
Posted by Michael Wonder on 24 Mar 2019
As political scrutiny mounts, Eli Lilly divulges new insulin pricing data
24 March 2019 - Lilly says the price it was paid for popular insulin Humalog fell 8.1% from 2014 to 2018 ...
Posted by Michael Wonder on 24 Mar 2019
Drug prices on TV? They may be coming.
23 March 2019 - The Trump administration is moving ahead with its proposal to require drug companies to disclose the ...
Posted by Michael Wonder on 23 Mar 2019
Drug company protections are latest stumbling block for NAFTA rewrite
21 March 2019 - President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge ...
Posted by Michael Wonder on 14 Mar 2019
How Eli Lilly’s new generic insulin could impact prices across the market
14 March 2019 - The list price is $137.35 per vial. ...
Posted by Michael Wonder on 04 Mar 2019
Eli Lilly rolling out half-price insulin. Diabetics say it's not enough.
4 March 2019 - Eli Lilly said it plans to roll out a half-price version of its Humalog insulin, an ...
Posted by Michael Wonder on 28 Feb 2019
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
28 February 2019 - U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, ...
Posted by Michael Wonder on 26 Feb 2019
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA chief says
26 February 2019 - "The sick people are helping to subsidise the healthy people. That's not how insurance is supposed to ...
Posted by Michael Wonder on 25 Feb 2019
Roche has a $5 billion chance to lead on drug prices
25 February 2019 - A deal for gene-therapy developer Spark could help reset what’s now an exorbitant corner of the market. ...
Posted by Michael Wonder on 21 Feb 2019
Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke
22 February 2019 - Catalyst Pharmaceuticals rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its ...
Posted by Michael Wonder on 13 Feb 2019
Mylan launches Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder), at a list price 70% less than the brand
12 February 2019 - Unique pricing of Wixela Inhub immediately benefits patients and reduces overall cost to the U.S. health care ...
Posted by Michael Wonder on 12 Feb 2019
Catalyst Pharma sees net price of drug, once free, topping $300,000
12 February 2019 - Catalyst Pharmaceuticals said on Monday that it expects its drug for a rare disease, which had ...